Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate in Ulcerative Colitis
NCT05781698Phase 2Completed
- Sponsor
- Tanta University
- Start
- Mar 2023
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of fenofibrate in ulcerative colitis (UC) (2 arms), sponsored by Tanta University. Primary endpoints: Disease Activity Index at 6 months and Health-Related Quality of Life at 6 months. Started Mar 2023; status: completed.
02
Drugs
fenofibrate
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT05781698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05781698.